Literature DB >> 7488111

The molecular basis of the self/nonself selectivity of a coelenterate toxin.

E Meinardi1, M Florin-Christensen, G Paratcha, J M Azcurra, J Florin-Christensen.   

Abstract

Coelenterates produce potent hemolysins inhibited by sphingomyelin (SM). Remarkably, instead of this lipid, their membranes contain a phosphono analogue of it. Using coelenterolysin (CL), a toxin produced by the sea anemone Phymactis clematis, we have examined a possible connection between these two peculiar traits. Our experiments showed that, while SM binds this lysin and inhibits its hemolytic activity, the endogenous PnSL do neither. In addition, liposomes made of bovine erythrocyte lipids are rapidly disrupted by CL, while those made of P. clematis lipids are completely resistant to it. However, if small amounts of SM are added to the P. clematis lipids, the resulting liposomes become sensitive to CL. Taken together, our results show for the first time that substitution of SM by its phosphono analogue is the molecular basis for the selectivity of an anthozoan toxin. We therefore propose that exotoxin production and membrane composition are coadapted traits that confer on the coelenterates a significant evolutionary advantage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488111     DOI: 10.1006/bbrc.1995.2630

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  A toxin-based probe reveals cytoplasmic exposure of Golgi sphingomyelin.

Authors:  Biserka Bakrac; Ales Kladnik; Peter Macek; Gavin McHaffie; Andreas Werner; Jeremy H Lakey; Gregor Anderluh
Journal:  J Biol Chem       Date:  2010-05-12       Impact factor: 5.157

2.  Characterization of the Lipid-Binding Site of Equinatoxin II by NMR and Molecular Dynamics Simulation.

Authors:  Daniel K Weber; Shenggen Yao; Nejc Rojko; Gregor Anderluh; Terry P Lybrand; Matthew T Downton; John Wagner; Frances Separovic
Journal:  Biophys J       Date:  2015-04-21       Impact factor: 4.033

3.  Effects of lipid composition on membrane permeabilization by sticholysin I and II, two cytolysins of the sea anemone Stichodactyla helianthus.

Authors:  C A Valcarcel; M Dalla Serra; C Potrich; I Bernhart; M Tejuca; D Martinez; F Pazos; M E Lanio; G Menestrina
Journal:  Biophys J       Date:  2001-06       Impact factor: 4.033

Review 4.  Comparison of Strategies to Overcome Drug Resistance: Learning from Various Kingdoms.

Authors:  Hiroshi Ogawara
Journal:  Molecules       Date:  2018-06-18       Impact factor: 4.411

5.  Effects of the eukaryotic pore-forming cytolysin Equinatoxin II on lipid membranes and the role of sphingomyelin.

Authors:  Boyan B Bonev; Yuen-Han Lam; Gregor Anderluh; Anthony Watts; Raymond S Norton; Frances Separovic
Journal:  Biophys J       Date:  2003-04       Impact factor: 4.033

6.  The innate immune repertoire in cnidaria--ancestral complexity and stochastic gene loss.

Authors:  David J Miller; Georg Hemmrich; Eldon E Ball; David C Hayward; Konstantin Khalturin; Noriko Funayama; Kiyokazu Agata; Thomas C G Bosch
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

7.  A RNA-seq approach to identify putative toxins from acrorhagi in aggressive and non-aggressive Anthopleura elegantissima polyps.

Authors:  Jason Macrander; Mercer R Brugler; Marymegan Daly
Journal:  BMC Genomics       Date:  2015-03-21       Impact factor: 3.969

8.  Oligomerization of Sticholysins from Förster Resonance Energy Transfer.

Authors:  Juan Palacios-Ortega; Esperanza Rivera-de-Torre; Sara García-Linares; José G Gavilanes; Álvaro Martínez-Del-Pozo; J Peter Slotte
Journal:  Biochemistry       Date:  2021-01-14       Impact factor: 3.162

Review 9.  Sea Anemones, Actinoporins, and Cholesterol.

Authors:  Juan Palacios-Ortega; Diego Heras-Márquez; Rafael Amigot-Sánchez; Carmen García-Montoya; Carlos Torrijos; Diego Laxalde; José G Gavilanes; Sara García-Linares; Álvaro Martínez-Del-Pozo
Journal:  Int J Mol Sci       Date:  2022-08-07       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.